ADENOCARD

This brand name is authorized in Brazil, Canada, United States

Active ingredients

The drug ADENOCARD contains one active pharmaceutical ingredient (API):

1 Adenine Deoxy Nucleoside UNII K72T3FS567 - ADENOSINE

Adenosine is a purine nucleoside which is present in all cells of the body. Animal pharmacology studies have in several species shown that adenosine has a negative dromotropic effect on the atrioventricular (AV) node. Read about Adenine Deoxy Nucleoside

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ADENOCARD Solution for injection	FDA, National Drug Code (US)	MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C01EB10	Adenosine	C Cardiovascular system → C01 Cardiac therapy → C01E Other cardiac preparations → C01EB Other cardiac preparations
Discover more medicines within C01EB10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 523700101153315, 523700102151316
Country: CA	Health Products and Food Branch	Identifier(s): 02145820
Country: US	FDA, National Drug Code	Identifier(s): 0469-8234